Reimagine Care
Virtual oncology symptom management and supportive care

Reimagine Care combines an AI-enabled assistant with oncology-trained clinicians for symptom monitoring, navigation, and support between cancer care visits.
Best for
- Oncology practices extending support beyond office hours and scheduled visits
- Cancer centers seeking technology plus additional oncology-trained clinical capacity
Not ideal for
- Patients seeking an alternative to their treating oncologist or emergency care
- Organizations expecting an automated assistant to manage complex symptoms without human escalation

Bottom line
Reimagine Care is worth considering for oncology organizations that need continuing symptom support and extra clinical capacity between appointments. Its value comes from connecting patient engagement technology to accessible oncology-trained people and the treating team.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Reimagine Care is relevant to oncology practices and cancer centers that want patients to reach help between visits without placing every call on the treating team. Thyme Care is an alternative for oncology navigation and supportive care. Their staffing, contracting, and population models should be compared against the same proposed service.
This is a clinical support partnership with technology and staff costs, not a consumer chatbot subscription. Cureety acquired Reimagine Care in September 2026, and the US Reimagine Care brand and oncology care model continue. The combined company’s broader footprint does not mean every US partner receives the same modules or staffing arrangement.
- Outcomes and workflow value (8.0): Published patient accounts and operating results support access and symptom-management value, while comparisons with national benchmarks have limitations.
- Product and service depth (8.2): Conversational engagement, symptom monitoring, care pathways, and oncology-trained teams create a substantive support service.
- Ease of implementation (7.1): Clinical workflow integration, escalation, enrollment, and care-team responsibilities need joint implementation.
- Pricing clarity (6.0): Enterprise service terms and reimbursement arrangements require a proposal, with no public complete price.
How Remi Connects Patients to Oncology Support
Remi is the company’s conversational assistant for engagement and symptom assessment. Reimagine Care connects that technology to evidence-based pathways, digital check-ins, and oncology-trained clinicians. The acquisition announcement describes escalation to human care teams when needed.
The service can help identify a change between visits and provide a route to appropriate support. It supplements the treating oncology team. Urgent symptoms, physical examinations, treatment changes, and emergency care still require the relevant clinical response and a clearly agreed escalation process.
What the Operating Results Show
The company’s about page labels its operating figures as 2025 data. It reports 151,000 assistant interactions, 16,000 live clinician interactions, and 30% fewer avoidable emergency-department visits than national benchmarks.
The benchmark is not a randomized comparison of identical patient groups. Differences in cancer type, treatment, enrollment, and support needs can affect results. The most useful local evaluation examines response times, escalation patterns, patient engagement, and avoidable utilization for the enrolled population.
The Cureety Acquisition and US Care Delivery
The September announcement combines Cureety’s therapy-specific monitoring and clinical intelligence with Reimagine Care’s US engagement and care teams. It describes an organization supporting more than 250 centers and 100,000 patients across five countries. Those are combined operating counts, not Reimagine Care-only customer counts.
The continuing US service is intended to integrate with oncology workflows and relevant care-management and remote-monitoring reimbursement pathways. A partner should establish its own staffing coverage, escalation duties, billing responsibilities, and integration scope. More complex therapies can make these operational details especially important.
Product and service details: reimaginecare.com, reimaginecare.com.
Company scale
Growjo estimates Reimagine Care’s annual revenue at $6.6 million. Scale source
What People Say
What people like
"I love Reimagine Care because sometimes I have good days and bad days. And I always have someone to talk to about how I’m feeling."
"I really appreciate being able to talk to a real person in a timely manner. I love you guys."
What people don't like
"We still need a clear handoff when a patient’s symptoms require the treating team or emergency care."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.
Based on: Product or service details, Product or service details.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Reimagine Care | 7.6 | 7.1 |
| Thyme Care | 7.6 | 7.2 |
| OncoHealth | 7.6 | 7.4 |
Pricing
| Item | Detail |
|---|---|
| Clinical partnership | Negotiated technology and clinical services agreement; no public complete dollar rate. |
| Reimbursement | The acquisition announcement discusses US care-management and remote-monitoring pathways; eligibility and billing responsibilities remain contract-specific. |
| Compare scope | Staff availability, enrolled population, monitoring, integrations, escalation, and reporting. |
Leadership
Recent news
- September 2026: Cureety acquired Reimagine Care, combining precision monitoring with the continuing US oncology support model.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- reimaginecare.com · about
- reimaginecare.com ·
- reimaginecare.com · publications/cureety acquires reimagine care
- reimaginecare.com · about/meet the team
